anti-Transglutaminase 3 (E Polypeptide, Protein-Glutamine-gamma-Glutamyltransferase) (TGM3) Antikörper

Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. Zusätzlich bieten wir Ihnen TGM3 Kits (26) und TGM3 Proteine (14) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
TGM3 7053 Q08188
TGM3 21818 Q08189
TGM3 366189 D4A5U3
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-TGM3 Antikörper auf antikoerper-online.de

Showing 10 out of 106 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Hund Kaninchen Unkonjugiert WB WB Suggested Anti-TGM3 Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:62500  Positive Control:  PANC1 cell lysate 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Human Ziege Unkonjugiert ELISA, WB   100 μg Anmelden zum Anzeigen 6 bis 7 Tage
$429.84
Details
Human Kaninchen Unkonjugiert IHC, IHC (p) Western Blot: Transglutaminase 3/TGM3 Antibody  - Analysis in human cell line RT-4, human cell line U-251 MG, human plasma, human liver tissue and human tonsil tissue. Immunohistochemistry-Paraffin: Transglutaminase 3/TGM3 Antibody  - Staining of human esophagus shows strong cytoplasmic and nuclear positivity in squamous epithelial cells. 0.1 mL Anmelden zum Anzeigen 10 bis 13 Tage
$494.38
Details
Hund Kaninchen Unkonjugiert WB 50 μg Anmelden zum Anzeigen 11 bis 14 Tage
$551.83
Details
Human Ziege Unkonjugiert ELISA, WB 100 μg Anmelden zum Anzeigen 11 bis 14 Tage
$610.50
Details
Human Kaninchen Unkonjugiert IF (p), IHC (p), WB Formalin-fixed and paraffin-embedded : rat brain tissue labeled withRabbit Anti-TGM3 Polyclonal Antibody , Unconjugated, 1:200 followed by conjugation to the secondary antibody Formalin-fixed and paraffin embedded mouse embryo labeled with Anti-TGM3 Polyclonal Antibody, Unconjugated (ABIN736253) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL Anmelden zum Anzeigen 3 bis 7 Tage
$329.45
Details
Human Kaninchen Unkonjugiert WB TGM3 Antibody (C-term)  western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the TGM3 antibody detected the TGM3 protein (arrow). 400 μL Anmelden zum Anzeigen 10 bis 11 Tage
$385.00
Details
Human Kaninchen Unkonjugiert ICC, IHC, WB Used in DAB staining on fromalin fixed paraffin-embedded ovary tissue 100 μg Anmelden zum Anzeigen 15 bis 18 Tage
$332.00
Details
Maus Kaninchen Unkonjugiert ICC, IHC, WB Figure. Western Blot; Sample: Mouse Tongue Tissue. 100 μg Anmelden zum Anzeigen 15 bis 18 Tage
$342.00
Details
Human Kaninchen Unkonjugiert EIA, IHC (fro), IF 0.1 mL Anmelden zum Anzeigen 6 bis 8 Tage
$742.50
Details

Am meisten referenzierte anti-TGM3 Antikörper

  1. Human Polyclonal TGM3 Primary Antibody für IF (p), IHC (p) - ABIN736253 : Kawabe, Takano, Moriyama, Nakamura: Transglutaminases Derived from Astrocytes Accelerate Amyloid β Aggregation. in Neurochemical research 2017 (PubMed)

  2. Human Polyclonal TGM3 Primary Antibody für ELISA, WB - ABIN4362114 : Yamane, Fukui, Sugimura, Itoh, Alea, Thomas, El Alaoui, Akiyama, Hitomi: Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles. in The FEBS journal 2010 (PubMed)

  3. Human Polyclonal TGM3 Primary Antibody für IHC, IHC (p) - ABIN4362113 : Uemura, Nakanishi, Kato, Saito, Nagino, Hirohashi, Kondo: Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. in International journal of cancer 2009 (PubMed)

Weitere Antikörper gegen TGM3 Interaktionspartner

Human Transglutaminase 3 (E Polypeptide, Protein-Glutamine-gamma-Glutamyltransferase) (TGM3) Interaktionspartner

  1. Patents having higher level of TGM-3 expression have good response to chemo-radiotherapy and also have better overall survival. TGM-3 may serve as a candidate biomarker for responsiveness to chemo-radiotherapy treatment in oral squamous cell carcinoma patients

  2. Cultured duodenal biopsies from patients with dermatitis herpetiformis produce transglutaminase-3 antibodies.

  3. Levels of TG3-IgA IC significantly elevated in plasma as well as in serum samples of untreated patients with dermatitis herpetiformis compared with healthy controls.

  4. studies demonstrate that TGase-catalyzed transamidation and activation of rac1 and cdc42 results from stimulation of multiple types of receptors and this novel signaling pathway can regulate dendritic spine morphology and plasticity.

  5. The two enzymes PADI3 and TGM3, responsible for posttranslational protein modifications, and their target structural protein TCHH are all involved in hair shaft formation.

  6. Data indicate a decrease in transglutaminases TG1 and TG3 transcripts by about 70% in foreskins from patients with balanitis xerotica obliterans (BXO) BXO in comparison with patients without BXO and an increase in transglutaminase TG2 mRNA levels by 2.9 fold.

  7. Our data collectively demonstrate that TGM3 can be a candidate tumor suppressor that is able to induce esophageal cancer cell proliferation and migration

  8. mRNA expression of transglutaminase 1 and transglutaminase 3 was significantly decreased in patients with chronic periodontitis compared with a healthy control group.

  9. Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen.

  10. New basal cell carcinoma susceptibility loci were identified at TGM3 (rs214782) and RGS22(rs7006527).

  11. IgA-anti-TG1 antibodies were found in 2% and IgA-anti-TG3 antibodies in 3% of patients with active atopic dermatitis (AD). Two out of the 5 patients with AD and concomitant celiac disease had IgA-anti-TG1 and IgA-anti-TG2 antibodies.

  12. TGM3, a candidate tumor suppressor, contributes to the carcinogenesis and development of human head and neck cancer.

  13. Genetic variation in the epidermal transglutaminase genes is not associated with atopic dermatitis.

  14. The low expression of TGM3 may contribute to the carcinogenesis and development of laryngeal carcinoma.

  15. TGM3 in immunoglobulin A (IgA) and TGM3 immune complexes is responsible for cross-linking and tight binding of IgA to connective tissue in the dermis and explains the IgA deposits in dermatitis herpetiformis skin long after signs of disease are resolved.

  16. findings lend credence to the notion that TG3 and TG6 are involved in the gluten-induced autoimmune responses of dermatitis herpetiformis and gluten ataxia

  17. new information on the specific distribution of TGase 3

  18. epidermal transglutaminase (type 3) is the dominant autoantigen in dermatitis herpetiformis

  19. x-ray crystallography in the presence of Ca2+ and/or Mg+2 shows Ca2+ binding in both sites two and three cooperate in opening the channel

  20. Expression in upper layers of epidermis. Diffuse cytoplasmic distribution in vitro consistent with its proposed role in early phase of cornified cell envelope assembly in cytoplasm.

Mouse (Murine) Transglutaminase 3 (E Polypeptide, Protein-Glutamine-gamma-Glutamyltransferase) (TGM3) Interaktionspartner

  1. study concludes that the classic wellhaarig mutations result from defects in Tgm3

  2. The mutant gene we is probably responsible for a disrupted induction signal from the dermal papilla towards ectodermal cells of a hair follicle.

  3. The first signs of alopecia in mice of the +/Fgf5(go-Y) we/wewal/wal genotype appear only three days later than in double +/+ we/wewal/wal homozygotes.

  4. Fluctuations of BMP2 signaling pathway during hair cycles in skin with mutant genes we, wal and Fgf5(go).

  5. Interaction of mutant genes Fgf5(go-Y), we, and wal changes the duration of hair growth cycles in mice

  6. The clinically uninvolved skin in TGM3 knockout mice showed impaired barrier function and higher susceptibility to FITC sensitization indicating that TGM3 has a significant contribution to the functionally intact cutaneous barrier.

  7. Loss of Tgm3 is associated with defective hair development.

  8. new information on the specific distribution of TGase 3

  9. N-terminus sequence of the proteolyzed fragment was analyzed with specific antibodies.

  10. The expression of TGM3 may play a important role in the epidermis differentiation in embryogenesis.

  11. detected two splicing variants for TG3, as the transcription of these mRNAs appears to be not regulated during differentiation and in pathologies involving tranglutaminase activity

TGM3 Antigen-Profil

Protein Überblick

Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene consists of two polypeptide chains activated from a single precursor protein by proteolysis. The encoded protein is involved the later stages of cell envelope formation in the epidermis and hair follicle.

Genbezeichner und Symbole assoziert mit TGM3

  • transglutaminase 3 (TGM3) Antikörper
  • transglutaminase 3, E polypeptide (Tgm3) Antikörper
  • transglutaminase 3 (Tgm3) Antikörper
  • AI893889 Antikörper
  • RGD1561831 Antikörper
  • TG(E) Antikörper
  • TGE Antikörper

Bezeichner auf Proteinebene für TGM3

E polypeptide, protein-glutamine-gamma-glutamyltransferase , TG(E) , TGase E , TGase-3 , protein-glutamine gamma-glutamyltransferase E , transglutaminase E , transglutaminase-3 , E polypeptide , TG E , TGE , protein-glutamine-gamma-glutamyltransferase

GENE ID SPEZIES
100053068 Equus caballus
7053 Homo sapiens
477180 Canis lupus familiaris
505080 Bos taurus
21818 Mus musculus
366189 Rattus norvegicus
Ausgewählte Anbieter für anti-TGM3 (TGM3) Antikörper
Haben Sie etwas anderes gesucht?